Gil M. Labrucherie
2015
In 2015, Gil M. Labrucherie earned a total compensation of $1.9M as Senior Vice President and General Counsel at Nektar Therapeutics, a 40% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $259,600 |
|---|---|
| Option Awards | $319,528 |
| Salary | $546,500 |
| Stock Awards | $808,594 |
| Other | $9,562 |
| Total | $1,943,784 |
Labrucherie received $808.6K in stock awards, accounting for 42% of the total pay in 2015.
Labrucherie also received $259.6K in non-equity incentive plan, $319.5K in option awards, $546.5K in salary and $9.6K in other compensation.
Rankings
In 2015, Gil M. Labrucherie's compensation ranked 4,837th out of 13,638 executives tracked by ExecPay. In other words, Labrucherie earned more than 64.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,837 out of 13,638 | 65th |
Division Manufacturing | 1,779 out of 5,190 | 66th |
Major group Chemicals And Allied Products | 631 out of 1,854 | 66th |
Industry group Drugs | 501 out of 1,528 | 67th |
Industry Pharmaceutical Preparations | 398 out of 1,182 | 66th |
Source: SEC filing on April 29, 2016.
Labrucherie's colleagues
We found five more compensation records of executives who worked with Gil M. Labrucherie at Nektar Therapeutics in 2015.
2015
Howard Robin
Nektar Therapeutics
Chief Executive Officer
2015
John Nicholson
Nektar Therapeutics
Chief Financial Officer
2015
Maninder Hora
Nektar Therapeutics
Senior Vice President Pharmaceutical Development and Manufacturing Operations
2015
Ivan Gergel
Nektar Therapeutics
Chief Medical Officer
2015
Stephen Doberstein
Nektar Therapeutics